Al. Racanelli et al., Inhibition of neointima formation by a nonpeptide alpha(v)beta(3) integrinreceptor antagonist in a rabbit cuff model, J CELL BIOC, 77(2), 2000, pp. 213-220
This study was performed to determine whether a highly selective nonpeptide
alpha(v)beta(3) antagonist (SH306) would prove effective in inhibiting neo
intima formation in a rabbit cuff model. The animals were dosed with SH306,
5 mg/kg i.v., followed by 10 mg/kg s.c., 3 times daily for 3 days, or with
vehicle (10% DMAC). Rabbits were sacrificed and perfused on days 1, 3, and
21; the vessels were paraffin embedded. A reduction in the intima/media (I
/M) of the SH306-treated rabbits, as compared with the vehicle-treated cont
rol group, was noted (0.20 vs 0.36 [n = 4]) A significant increase in the a
rea of the media was observed in the SH306-treated group versus the control
group (0.20 vs 0.13). No difference was observed in cell proliferation bet
ween SH306 and vehicle after 1-day and 3-day dosing. Thrombi were found in
43% of the control vessels and in only 14% of the drug-treated vessels. No
anticoagulant was used during the surgical procedure. No increase in inhibi
tion of GPIIb/IIIa was observed in SH306-treated animals, as compared with
the vehicle control group. We conclude that selective inhibition of alpha(v
)beta(3) reduced neointima formation in a rabbit model at 3 weeks. (C) 2000
Wiley-Liss, Inc.